A new study published by JAMA Network Open has found that the mass production of fake anti-malaria drugs have become pervasive in low- and middle-income countries targeting markets in Africa and other developing countries.
Nigeria is the single most heavily malaria-burdened country in the wor
```
Members Only
Login or create an account to continue
This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.
New to BusinessDay? Register now and start reading.
```
